Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec 8.
doi: 10.1111/cge.70118. Online ahead of print.

Prevalence and Spectrum of Congenital Heart Disease in Individuals With Distal Chromosome 22q11.22-23 Deletions

Affiliations

Prevalence and Spectrum of Congenital Heart Disease in Individuals With Distal Chromosome 22q11.22-23 Deletions

Tanner J Nelson et al. Clin Genet. .

Abstract

This study is aimed at determining the spectrum of congenital heart disease associated with distal 22q11.22-23 deletions flanked by low copy repeats, LCR22 D-H. We analyzed cardiology findings in 128 unrelated individuals with distal LCR22 D-H deletions. A total of 62 were newly described and 66 were derived from previous reports. We found that deletions which included LCR22-D as the proximal endpoint were the most prevalent in the cohort (104/128, 81.3%). Clinically relevant congenital heart disease was identified in 48 individuals (37.5%, 95% CI 29%-46%), which is lower than the prevalence reported for typical, proximal LCR22 A-D deletions (p = 3.7E-4), especially for conotruncal defects (13/128, 10.2%; p = 7.1E-13). Mild to moderate CHD predominated, including ventricular septal defects (22/128), bicuspid aortic valve (9/128) and mild cardiomyopathy (3/128). Persistent truncus arteriosus was the most prevalent (n = 8/13) conotruncal heart defect, but other anomalies also occurred in singleton cases. These findings support the need for cardiac evaluation in all individuals with distal 22q11.22-23 deletions, increased use of clinical genetic testing in syndromic individuals with these findings, and molecular studies in model systems. The results demonstrate that reduced gene dosage of distal 22q11.21-23, particularly within the D-E region including MAPK1 and HIC2 convey risk for CHD.

Keywords: 22q11.2 distal deletion; chromosome abnormalities; chromosome deletion; congenital heart disease; heart defects‐congenital.

PubMed Disclaimer

References

    1. L. Edelmann, R. K. Pandita, and B. E. Morrow, “Low‐Copy Repeats Mediate the Common 3‐Mb Deletion in Patients With Velo‐Cardio‐Facial Syndrome,” American Journal of Human Genetics 64, no. 4 (1999): 1076–1086.
    1. L. Edelmann, R. K. Pandita, E. Spiteri, et al., “A Common Molecular Basis for Rearrangement Disorders on Chromosome 22q11,” Human Molecular Genetics 8, no. 7 (1999): 1157–1167.
    1. T. H. Shaikh, H. Kurahashi, S. C. Saitta, et al., “Chromosome 22‐Specific Low Copy Repeats and the 22q11.2 Deletion Syndrome: Genomic Organization and Deletion Endpoint Analysis,” Human Molecular Genetics 9, no. 4 (2000): 489–501.
    1. R. D. Burnside, “22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features,” Cytogenetic and Genome Research 146, no. 2 (2015): 89–99.
    1. E. Goldmuntz, D. Driscoll, M. L. Budarf, et al., “Microdeletions of Chromosomal Region 22q11 in Patients With Congenital Conotruncal Cardiac Defects,” Journal of Medical Genetics 30, no. 10 (1993): 807–812.

LinkOut - more resources